Watchmaker Genomics
Boulder, US · Founded 2018 · Delaware corporation · 277 employees on LinkedIn · 2 known investors
Find your way into Watchmaker Genomics
500 people in our graph share verified history with the Watchmaker Genomics team — schools, employers, funds. One of them is your warm intro.
Avron Marcusunlockedknows Eric van der Walt · together at University of Cape Town (overlapped)
×5knows the team · via PwC
×2knows the team · via Purdue University
×4knows the team · via University of Cape Town
Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research. It operates as an OEM supplier serving genomics technology developers and high-throughput sequencing labs.
Founders & leadership
Watchmaker Genomics was founded in 2018 by John Foskett.
JF
John FoskettFounder
BD
Brian DeneauinChief Operating and Finance OfficerHe holds a bachelor's degree in accounting from Purdue University and is a certified public accountant with prior healthcare industry experience in strategic planning, management, and operations.
SP
Stephen PiconeinCo-Founder
BK
Brian KudlowinCo-Founder
TF
Trey FoskettinChief Executive Officer
KS
Kerri StellatoinChief Commercial Officer
EV
Eric van der WaltinChief Innovation Officer and Managing Director, South AfricaHe has extensive research and development experience in biotechnology, with expertise in DNA sequencing, cell culture, and genomics.
PM
Paul McEwanNamed on SEC filing
CM
Christopher McGuinnessNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$48.3M disclosed across 2 rounds · 2020–2022
▶$40MraisedJun 2022 · 2 investors · OtherRule 506(b)
▶$40MraisedJun 2022 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Stephen PiconeExecutive Officer, Director, Promoter
- Brian KudlowExecutive Officer, Director, Promoter
- Brian DeneauExecutive Officer
- Paul McEwanDirector, Promoter
- Victor TongDirector
- John FoskettExecutive Officer, Director, Promoter
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$8.3MraisedDec 2020 · 27 investors · OtherRule 506(b)
▶$8.3MraisedDec 2020 · 27 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Paul McEwanDirector, Promoter
- Christopher McGuinnessDirector
- John FoskettExecutive Officer, Director, Promoter
- Brian DeneauExecutive Officer, Director
- Stephen PiconeExecutive Officer, Director, Promoter
- Brian KudlowExecutive Officer, Director, Promoter
- Offering amount
- $8.3M
- Amount sold
- $8.3M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Watchmaker Genomics do?
- Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research. It operates as an OEM supplier serving genomics technology developers and high-throughput sequencing labs.
- Who founded Watchmaker Genomics?
- Watchmaker Genomics was founded by John Foskett in 2018.
- Who are Watchmaker Genomics's investors?
- Watchmaker Genomics's investors include Decheng Capital, Eclipse Ventures.
- How much funding has Watchmaker Genomics raised?
- Watchmaker Genomics has disclosed $48.3M raised across 2 rounds.
- Where is Watchmaker Genomics headquartered?
- Watchmaker Genomics is headquartered in Boulder, US.